Vera Therapeutics (VERA) Short Interest Ratio & Short Volume $26.34 +1.80 (+7.33%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$26.50 +0.16 (+0.59%) As of 08:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vera Therapeutics Short Interest DataVera Therapeutics (VERA) has a short interest of 8.48 million shares, representing 17.47% of the float (the number of shares available for trading by the public). This marks a 9.14% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.6, indicating that it would take 5.6 days of the average trading volume of 1.76 million shares to cover all short positions.Current Short Interest8,480,000 sharesPrevious Short Interest7,770,000 sharesChange Vs. Previous Month+9.14%Dollar Volume Sold Short$183.51 millionShort Interest Ratio5.6 Days to CoverLast Record DateAugust 31, 2025Outstanding Shares63,820,000 sharesFloat Size48,530,000 sharesShort Percent of Float17.47%Today's Trading Volume1,747,208 sharesAverage Trading Volume1,755,185 sharesToday's Volume Vs. Average100% Short Selling Vera Therapeutics? Sign up to receive the latest short interest report for Vera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVERA Short Interest Over TimeVERA Days to Cover Over TimeVERA Percentage of Float Shorted Over Time Vera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/20258,480,000 shares $183.51 million +9.1%17.5%5.6 $21.64 8/15/20257,770,000 shares $167.37 million +2.6%16.0%4.2 $21.54 7/31/20257,570,000 shares $157.38 million -8.1%15.9%4.5 $20.79 7/15/20258,240,000 shares $191.17 million +5,059.7%18.1%4.8 $23.20 6/30/2025159,700 shares $3.76 million -98.3%0.2%0.7 $23.56 6/15/20259,560,000 shares $217.39 million +6.8%20.8%5.5 $22.74 5/31/20258,950,000 shares $170.23 million +26.6%18.6%5.7 $19.02 5/15/20257,070,000 shares $150.80 million +18.6%14.7%7.1 $21.33 4/30/20255,960,000 shares $139.29 million -2.0%12.2%5.4 $23.37 4/15/20256,080,000 shares $131.27 million -7.0%12.4%6.4 $21.59 Get the Latest News and Ratings for VERA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/31/20256,540,000 shares $157.09 million -9.8%13.4%7 $24.02 3/15/20257,250,000 shares $202.93 million -7.1%14.8%8.6 $27.99 2/28/20257,800,000 shares $233.45 million -6.7%15.9%9.8 $29.93 2/15/20258,360,000 shares $229.57 million +3.2%17.2%11 $27.46 1/31/20258,100,000 shares $301.97 million +11.1%16.6%12.2 $37.28 1/15/20257,290,000 shares $246.99 million +2.0%14.9%9.2 $33.88 12/31/20247,150,000 shares $302.37 million +5.2%14.6%9.8 $42.29 12/15/20246,800,000 shares $299.54 million +4.3%13.9%9.3 $44.05 11/30/20246,520,000 shares $324.37 million -0.5%13.3%8.6 $49.75 11/15/20246,550,000 shares $303.00 million +2.5%14.0%8.7 $46.26 10/31/20246,390,000 shares $258.03 million +3.2%13.3%9 $40.38 10/15/20246,190,000 shares $248.90 million +0.3%14.9%11.7 $40.21 9/30/20246,170,000 shares $272.71 million -4.5%14.9%11.3 $44.20 9/15/20246,460,000 shares $242.31 million +6.8%15.6%11.6 $37.51 8/31/20246,050,000 shares $228.81 million -0.5%14.6%11.3 $37.82 8/15/20246,080,000 shares $226.42 million -0.2%14.7%9.9 $37.24 7/31/20246,090,000 shares $222.83 million +1.7%14.7%9.4 $36.59 7/15/20245,990,000 shares $220.13 million -2.1%14.4%8.2 $36.75 6/30/20246,120,000 shares $221.42 million -0.1%14.7%6.9 $36.18 6/15/20246,123,800 shares $220.58 million +0.9%14.7%6.7 $36.02 5/31/20246,070,000 shares $230.60 million -6.0%14.5%6.6 $37.99 5/15/20246,460,000 shares $275.78 million -5.0%15.5%6.7 $42.69 4/30/20246,800,000 shares $268.67 million +7.8%16.6%6.5 $39.51 4/15/20246,310,000 shares $293.60 million -0.3%16.1%4.5 $46.53 3/31/20246,330,000 shares $272.95 million +1.4%16.1%4.9 $43.12 3/15/20246,240,000 shares $269.88 million +0.7%16.2%5.1 $43.25 2/29/20246,200,000 shares $291.90 million -8.4%16.5%5.3 $47.08 2/15/20246,770,000 shares $308.10 million +2.4%19.6%6.3 $45.51 1/31/20246,610,000 shares $240.74 million +9.3%19.1%6.6 $36.42 1/15/20246,050,000 shares $114.65 million -3.7%21.5%10.3 $18.95 12/31/20236,280,000 shares $96.59 million +11.2%22.2%11.3 $15.38 12/15/20235,650,000 shares $90.40 million +5.6%20.0%10.7 $16.00 11/30/20235,350,000 shares $72.49 million +6.6%19.0%9.3 $13.55 11/15/20235,020,000 shares $67.07 million +1.2%17.8%8.5 $13.36 10/31/20234,960,000 shares $51.68 million -9.3%17.8%8.8 $10.42 10/15/20235,470,000 shares $58.20 million +11.9%19.9%10.7 $10.64 9/30/20234,890,000 shares $67.04 million +32.9%17.8%10.3 $13.71 9/15/20233,680,000 shares $62.89 million -2.9%13.4%7.3 $17.09 8/31/20233,790,000 shares $67.05 million +15.9%13.8%5.4 $17.69 8/15/20233,270,000 shares $57.85 million +6.2%11.9%4.7 $17.69 7/31/20233,080,000 shares $57.81 million -8.3%11.1%4.5 $18.77 7/15/20233,360,000 shares $56.92 million -2.6%12.3%5 $16.94 6/30/20233,450,000 shares $55.37 million -3.1%12.7%5.1 $16.05 6/15/20233,560,000 shares $45.28 million +24.5%13.4%5.6 $12.72 5/31/20232,860,000 shares $23.88 million -5.0%10.8%7.3 $8.35 5/15/20233,010,000 shares $23.99 million -9.1%11.3%7.5 $7.97 4/30/20233,310,000 shares $22.01 million +30.3%14.2%7.1 $6.65 4/15/20232,540,000 shares $15.93 million -28.9%9.7%4.6 $6.27 3/31/20233,570,000 shares $27.70 million +32.7%14.2%5.4 $7.76 3/15/20232,690,000 shares $19.18 million +15.5%10.7%3.2 $7.13 2/28/20232,330,000 shares $17.31 million +3.6%9.1%3 $7.43 2/15/20232,250,000 shares $17.71 million +47.1%8.8%3.1 $7.87 1/31/20231,530,000 shares $12.97 million +23.4%7.6%2.3 $8.48 1/15/20231,240,000 shares $8.36 million -12.1%9.3%2.4 $6.74 12/30/20221,410,000 shares $27.28 million -7.2%10.6%3.4 $19.35 12/15/20221,520,000 shares $29.14 million -22.1%11.4%11.7 $19.17 11/30/20221,950,000 shares $32.57 million -4.9%14.7%16 $16.70 11/15/20222,050,000 shares $34.54 million +15.8%15.5%18.9 $16.85 10/31/20221,770,000 shares $32.99 million +10.6%14.7%18.1 $18.64 10/15/20221,600,000 shares $30.69 million -1.2%13.3%18.6 $19.18 9/30/20221,620,000 shares $34.52 million +14.9%13.4%18.8 $21.31 9/15/20221,410,000 shares $30.13 million -10.2%11.7%16.2 $21.37 8/31/20221,570,000 shares $34.12 million +4.0%13.2%18 $21.73 8/15/20221,510,000 shares $32.69 million +14.4%12.6%18.9 $21.65 7/31/20221,320,000 shares $22.77 million +16.8%11.1%15 $17.25 7/15/20221,130,000 shares $18.14 million +20.1%9.5%12 $16.05 6/30/2022941,300 shares $12.81 million +28.2%7.9%10.2 $13.61 6/15/2022734,500 shares $10.28 million +83.6%6.2%8.2 $13.99 5/31/2022400,000 shares $5.82 million -12.5%3.3%4.1 $14.54 5/15/2022456,900 shares $6.99 million +8.1%3.8%4.7 $15.29 4/30/2022422,600 shares $8.45 million +41.2%3.4%3.6 $20.00 4/15/2022299,200 shares $6.92 million -46.3%2.4%2.7 $23.12 3/31/2022557,000 shares $13.08 million +40.1%4.5%5.3 $23.49 3/15/2022397,700 shares $9.55 million +39.1%3.1%3.6 $24.01 2/28/2022286,000 shares $6.64 million -16.7%2.2%2.8 $23.21 2/15/2022343,400 shares $6.81 million -4.3%3.7%3.5 $19.83 1/31/2022358,800 shares $7.15 million +27.9%4.9%5.2 $19.93 1/15/2022280,600 shares $5.61 million +15.6%3.8%4.6 $19.99 12/31/2021242,700 shares $6.48 million +185.2%3.3%4.2 $26.72 12/15/202185,100 shares $1.92 million +7.2%1.2%1.4 $22.51 11/30/202179,400 shares $2.84 million -36.6%1.1%1 $35.80 11/15/2021125,200 shares $2.93 million -32.4%1.7%1.6 $23.40 10/29/2021185,100 shares $3.58 million +43.8%2.5%2.6 $19.35 10/15/2021128,700 shares $1.93 million +15.8%1.7%1.8 $15.01 9/30/2021111,100 shares $1.93 million +376.8%1.5%1.7 $17.35 9/15/202123,300 shares $712.98 thousand +651.6%0.3%0.4 $30.60 8/31/20213,100 shares $45.69 thousand +24.0%0.0%0.1 $14.74 8/13/20212,500 shares $42.35 thousand No Change0.0%0.1 $16.94 VERA Short Interest - Frequently Asked Questions What is Vera Therapeutics' current short interest? Short interest is the volume of Vera Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 8,480,000 shares of VERA short. 17.47% of Vera Therapeutics' shares are currently sold short. Learn More on Vera Therapeutics' current short interest. What is a good short interest ratio for Vera Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VERA shares currently have a short interest ratio of 6.0. Learn More on Vera Therapeutics's short interest ratio. Which institutional investors are shorting Vera Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vera Therapeutics: Group One Trading LLC, Jane Street Group LLC, Walleye Capital LLC, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vera Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.47% of Vera Therapeutics' floating shares are currently sold short. Is Vera Therapeutics' short interest increasing or decreasing? Vera Therapeutics saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 8,480,000 shares, an increase of 9.1% from the previous total of 7,770,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vera Therapeutics' float size? Vera Therapeutics currently has issued a total of 63,820,000 shares. Some of Vera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vera Therapeutics currently has a public float of 48,530,000 shares. How does Vera Therapeutics' short interest compare to its competitors? 17.47% of Vera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vera Therapeutics: Nuvalent, Inc. (12.29%), TG Therapeutics, Inc. (17.29%), Merus N.V. (5.99%), CRISPR Therapeutics AG (25.36%), PTC Therapeutics, Inc. (8.85%), Krystal Biotech, Inc. (13.81%), Vaxcyte, Inc. (9.15%), ACADIA Pharmaceuticals Inc. (7.48%), Arcellx, Inc. (16.94%), ADMA Biologics Inc (6.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks. What does it mean to sell short Vera Therapeutics stock? Short selling VERA is an investing strategy that aims to generate trading profit from Vera Therapeutics as its price is falling. VERA shares are trading up $1.80 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vera Therapeutics? A short squeeze for Vera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VERA, which in turn drives the price of the stock up even further. How often is Vera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VERA, twice per month. The most recent reporting period available is August, 31 2025. More Short Interest Resources from MarketBeat Related Companies NUVL Short Interest TGTX Short Interest MRUS Short Interest CRSP Short Interest PTCT Short Interest KRYS Short Interest PCVX Short Interest ACAD Short Interest ACLX Short Interest ADMA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VERA) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
